DISCOVERY LIFE SCIENCES Executive and Leadership Team

Gregory Herrema, the Chief Executive Officer at DISCOVERY LIFE SCIENCES, directs the overarching corporate strategy and long-term vision for the organization. By aligning scientific capabilities with the evolving needs of the pharmaceutical and biotechnology sectors, the Chief Executive Officer ensures the company maintains its position as a global leader in biospecimen analysis and genomic research. Herrema oversees the integration of HudsonAlpha Discovery into the broader service portfolio, driving expansion across international markets. This leadership role involves constant collaboration with the board to optimize capital allocation and operational efficiency. Through a consultative approach to client partnerships, Gregory Herrema fosters an environment of innovation that accelerates drug discovery and clinical research outcomes. Ultimately, the Chief Executive Officer secures the financial health and market influence of the firm while championing the mission to provide high-quality scientific services to researchers worldwide.

Jay Scherer, the Chief Operating Officer at DISCOVERY LIFE SCIENCES, manages the daily execution of global laboratory operations and supply chain logistics. Overseeing the infrastructure required for complex biospecimen procurement and distribution, the Chief Operating Officer ensures that all scientific services meet rigorous quality standards for diagnostic and clinical partners. Scherer coordinates cross-functional teams to streamline workflows, reducing turnaround times for critical research projects. This role involves managing the operational footprint across diverse geographic regions to support the scaling of genomic sequencing capabilities. By implementing robust process improvements, Jay Scherer directly enhances the efficiency of the company's service delivery model. The Chief Operating Officer maintains alignment between internal resource allocation and the high-volume demands of the biotechnology industry, ensuring that the organization consistently delivers reliable, high-quality data to clients engaged in translational research.

McLean Collins, the President, Biospecimens Products & Services at DISCOVERY LIFE SCIENCES, directs the specialized division responsible for the procurement, processing, and distribution of high-quality biological samples. Overseeing the technical standards and regulatory compliance for all biospecimen products, the President, Biospecimens Products & Services ensures that researchers receive the precise materials required for clinical and diagnostic development. Collins manages the integration of advanced laboratory technologies to enhance the quality and utility of the company's inventory. This leadership role involves collaborating with the sequencing division to provide comprehensive, end-to-end research solutions for global clients. By refining the supply chain for rare and complex samples, McLean Collins directly supports the acceleration of drug discovery efforts. The President, Biospecimens Products & Services maintains a focus on operational excellence, ensuring that the division remains the preferred partner for pharmaceutical companies seeking reliable, ethically sourced biological assets for their critical research programs.

Tamara Bowles, the Chief Human Resources Officer at DISCOVERY LIFE SCIENCES, architects the talent acquisition and organizational development strategies necessary to support a high-growth scientific enterprise. Overseeing the recruitment of specialized genomic researchers and laboratory personnel, the Chief Human Resources Officer ensures the company attracts top-tier expertise to maintain its competitive edge. Bowles designs comprehensive training programs that foster a culture of innovation and scientific excellence. This leadership role involves managing employee engagement initiatives and performance management systems that align individual contributions with the broader corporate mission. By cultivating a diverse and inclusive workforce, Tamara Bowles strengthens the internal capabilities required for complex biospecimen analysis. The Chief Human Resources Officer also directs the implementation of scalable human capital policies that support the company's expansion into new global markets, ensuring that the organizational structure remains agile and responsive to the needs of the pharmaceutical industry.

Steve Hagan, the Chief Sales Officer at DISCOVERY LIFE SCIENCES, drives the commercial strategy and revenue growth initiatives across the global pharmaceutical and diagnostics markets. Overseeing the sales force and client relationship management teams, the Chief Sales Officer ensures that the company's consultative approach effectively addresses the specific research obstacles faced by biotechnology partners. Hagan manages the expansion of the client base, focusing on securing long-term partnerships for biospecimen procurement and genomic sequencing services. This role involves coordinating with the marketing and product teams to tailor service offerings to emerging industry trends. By optimizing the sales funnel and enhancing customer engagement, Steve Hagan directly impacts the company's market penetration and financial performance. The Chief Sales Officer maintains a deep understanding of the competitive landscape, allowing the organization to pivot its commercial efforts to capture new opportunities in the rapidly evolving field of translational research.